Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant | MicrobiomeTrials← Back to trialsNCT05722210
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-14Est. Completion: 2031-06-30
Enrollment target: 500 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host DiseaseBronchiolitis Obliterans Syndrome
Background:
Bronchiolitis obliterans syndrome (BOS) is a complication people can experience after hematopoietic stem ce…
Bethesda, United StatesEst. completion Dec 1, 2027
Malignancy, HematologicNeoplasms, HematologicNeoplasms, HematopoieticBlood CancerHematological Neoplasms
Hematopoietic Malignancies
Dysmyelopoietic Syndromes
Hematopoetic Myelodysplasia
Myeloid Leukemia, Acute
Nonlymphoblastic Leukemia, Acute
Leukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United StatesEst. completion Apr 30, 2029
Hypoplastic Acute Myeloid LeukemiaSecondary AML (Adult)
The purpose of this study is to explore the efficacy and safety of venetoclax combined with azacitidine（VA) induction fo…
Suzhou, ChinaEst. completion May 31, 2029